Lund University

In a deal that Aspect Biosystems Ltd. CEO Tamer Mohamed suggested could mean science fiction coming to real life, the Vancouver, BC-based firm focused on bioprinted tissue therapeutics is teaming wi

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. China Grand Alliance With eTheRNA Follo

Gossamer Bio Inc. emerged from stealth mode with a lot of fanfare in 2018, revealing a $100m Series A venture capital round in January and a $230m Series B round in July. And it appears that the comp

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in